Author: <span>Mesothelioma News</span>

Five Prime Therapeutics, Inc. Announces Second Quarter 2014 Financial Results

Five Prime Therapeutics, Inc. , a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today provided a corporate update and reported financial results for the secon…